Estradiol valerate/dienogest: a novel combined oral contraceptive
LM Borgelt, CW Martell - Clinical therapeutics, 2012 - Elsevier
BACKGROUND: Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive
LM Borgelt, CW Martell - Clinical Therapeutics, 2012 - infona.pl
Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive (COC) with 2 new
hormonal entities and a unique 4-phasic dosing regimen indicated for women to prevent …
hormonal entities and a unique 4-phasic dosing regimen indicated for women to prevent …
[引用][C] Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive
LM BORGELT, CW MARTELL - Clinical therapeutics, 2012 - pascal-francis.inist.fr
Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive
LM Borgelt, CW Martell - 2012 - epublications.regis.edu
Background: Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
Estradiol valerate/dienogest: a novel combined oral contraceptive.
LM Borgelt, CW Martell - Clinical Therapeutics, 2011 - europepmc.org
Background Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
Estradiol valerate/dienogest: a novel combined oral contraceptive
LM Borgelt, CW Martell - Clinical therapeutics, 2012 - pubmed.ncbi.nlm.nih.gov
Background Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive
LM Borgelt, CW Martell - Clinical Therapeutics, 2012 - clinicaltherapeutics.com
Background Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …
[引用][C] Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive
L Borgelt, C Martell - Clinical Therapeutics, 2012 - epublications.regis.edu
"Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive" by Laura Borgelt and
Chad Martell Home Search Browse Collections My Account About DC Network Digital …
Chad Martell Home Search Browse Collections My Account About DC Network Digital …